
Background: Takotsubo syndrome (TTS) features transient left ventricular (LV) dysfunction, often with myocardial edema and impaired coronary microcirculation. The relationships between myocardial edema, blood flow, and LV contractility remain unclear. We retrospectively examined these associations using cardiac magnetic resonance (CMR) and positron emission tomography (PET). Methods: TTS patients were included if they underwent CMR and PET within 30 days of admission and <= 7 days apart. Correlations between CMR-derived T2 and PET-derived stress myocardial blood flow (MBF), myocardial flow reserve (MFR), and coronary vascular resistance (CVR) were analyzed regionally and globally. For regional analysis, the left ventricle was divided into basal, mid, and apical segments, each classified by wall motion (normal, hypokinesis, akinesis, and dyskinesis) to compare T2, stress MBF, and CVR. Global analyses included correlations using global values and longitudinal gradients. Parameters were also compared with cine CMR-derived global longitudinal strain (GLS). Results: Of 67 patients screened, 43 (mean age: 69 years; 98% female) were included, yielding 129 regions: 62 normokinetic (48%), 14 hypokinetic (11%), 44 akinetic (34%), and 9 dyskinetic (7%). Regionally, higher T2 was associated with lower stress MBF and MFR and higher CVR. T2, stress MBF, and CVR varied stepwise with wall-motion severity. Globally, both T2 and longitudinal T2 gradients correlated with stress MBF and CVR. Longitudinal gradients of T2, stress MBF, and CVR were significantly associated with GLS. Conclusions: In TTS, myocardial edema is associated with reduced stress MBF and higher CVR, and these abnormalities track with LV contractility. Longitudinal gradients may provide greater clinical relevance than global measures.
Background: Cardiac sarcoidosis follows a relapsing-remitting course, but imaging patterns and predictors of relapse remain poorly defined. The aim of this study was to characterize spatial and metabolic features of relapse in cardiac sarcoidosis and identify predictors using serial 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). Methods: Patients with cardiac sarcoidosis who underwent three serial FDG-PET & horbar;baseline (PET 1), response (PET 2), and follow-up (PET 3)& horbar;at a tertiary center in Toronto, Canada (2011-2024), were included in the study. Eligibility required abnormal myocardial FDG uptake at PET 1 and metabolic response at PET 2, defined as >20% reduction in total cardiac metabolic activity (tCMA) relative to PET 1. Left ventricular segmental FDG analysis assessed spatial patterns. Candidate predictors included baseline inflammatory burden and response-phase imaging features. Imaging-defined relapse was defined as a >20% increase in tCMA from PET 2 to PET 3. Logistic regression identified predictors. Results: Among 50 patients (median age: 54 years; 60% male), 23 (46%) had relapse. Most relapses (91%) occurred in previously affected myocardial segments, with 70% showing lower FDG intensity and extent. Relapsed patients had higher baseline tCMA (564.0 vs 120.1; P = 0.006) and more extracardiac involvement (2.61 vs 1.19 organs; P = 0.01). Higher odds of relapse were observed among patients with residual myocardial FDG uptake (adjusted odds ratio: 5.30; 95% confidence interval: 1.14-29.13; P = 0.039). Conclusions: Relapse occurred in nearly half of patients after an initial response, typically involving previously affected myocardial regions with lower inflammatory burden. Residual FDG uptake on response-phase imaging was associated with relapse, supporting the role of serial FDG-PET for surveillance in cardiac sarcoidosis.